Amivas, LLC
Pharmaceutical company
Based in DE
🤖
AI Overview
With $100K in lobbying spend across 26 quarterly filings, Amivas, LLC is an active lobbying client. Their lobbying covers 4 issue areas. Active from 2019 to 2023.
$100K
Total Spend
5
Years Active
1
Firms Hired
4
Lobbyists Deployed
4
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2019 | $40K |
| 2020 | $60K |
| 2021 | $0 |
| 2022 | $0 |
| 2023 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Veterans, Homeland Security, MED, Health Issues
- •Federal government relations service, strategy development and implementation relating to replacements for quinidine gluconate for treating severe malaria in the US.
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.